Answers are grounded in this paper and cite their sources.
To compare serum neuroinflammatory and brain damage biomarkers between Cognitively Impaired and Unimpaired patients at baseline, 3/6, and 12 months after COVID-19 hospitalization.
No takes yet. Share an insight, caveat, or question.
Maziero et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: